2023 Pharmacology Safety 
Pharmaceutical Representative Training
JANUARY 8, 2025
Pharmacology is one of the most fundamental aspects of medication therapy. Without this information, providers cant ensure the safety or efficacy of the medications they prescribe. 1] How can mastering pharmacology give sales reps a competitive advantage when meeting with prospective HCPs?
European Pharmaceutical Review
JULY 13, 2023
While this is essential in the interrogation of novel compounds for which we know very little about their efficacy and safety, it is also true that some biomedical research is highly wasteful. Available from: [link] [Last Accessed: 31st May 2023] Olsson F, Erridge S, Tait J, et al. Expert Review of Clinical Pharmacology.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
European Pharmaceutical Review
JULY 19, 2023
The data “are compelling, particularly the significant improvements observed in both depressive and anhedonic symptoms,” stated Dr Roger S McIntyre, FRCPC, Professor of psychiatry and pharmacology, University of Toronto and Executive Director of the Brain and Cognition Discovery Foundation in Toronto, Canada.
Pharmaceutical Technology
MAY 11, 2023
Rexulti has become the first and only pharmacological treatment to receive approval for this indication in the US. The regulator accepted and gr anted priority review for the sNDA in January 2023. Brexpiprazole was found to be well-tolerated and its safety profile was consistent with its known safety profile in other indications.
European Pharmaceutical Review
DECEMBER 11, 2023
mAbs have well-established safety profiles, high specificity and affinity and long half-lives – they have been used in drug development for more than 30 years. Known linkers in the RNA field are used to bond together the two pharmacologically active molecular entities and can be applied to multiple oligonucleotide modalities.
Impetus Digital
AUGUST 2, 2024
Looking back at 2023 , AI for drug discovery saw both wins and losses. To avoid compliance issues , it is essential to keep up with new regulatory changes, including updated reporting guidelines and safety requirements. In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%.
European Pharmaceutical Review
JULY 4, 2024
The FDA’s role in the regulation of botanical drug products includes an assessment of their safety and efficiency 5 but insufficient evidence for efficacy is one of the most common reasons why new drug candidates fail to reach this step. 10,12 The THR scheme is also limited to products used for oral or external use and/or inhalation.
Expert insights. Personalized for you.
52 
Let's personalize your content